Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00495144
Status:
COMPLETED
Last Update Posted:
2012-07-27
First Post:
2007-06-28
Brief Title:
A Phase I Study of the Safety Pharmacokinetics and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors
Sponsor:
Threshold Pharmaceuticals
Organization:
Threshold Pharmaceuticals